ENTITY
SMARTSCORE: 2.8/5
Shanghai Medicilon

Shanghai Medicilon (688202 CH)

55
Analysis
Health CareChina
Shanghai Medicilon Inc. develops pharmaceutical products. The Company produces acquired immune deficiency syndrome drugs, anticancer drug sensitizers, genetic engineering vaccines, biomedical intermediates, and other products. Shanghai Medicilon also provides biological analysis, drug safety evaluation, and other services.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x